Loading…
COVID–19 Supply Chain Resiliency Act of 2021
Legislative Progress
Introduced
February 11, 2021
Latest Action
February 12, 2021
Primary Sponsor
Bradley Scott SchneiderDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
COVID-19 Supply Chain Resiliency Act of 2021 This bill establishes the Office of COVID-19 Supply Chain Resiliency to identify and address supply chain issues related to the COVID-19 (i.e., coronavirus disease 2019) pandemic. Specifically, the office must establish a national strategy to address identified supply chain issues related to the pandemic, serve as a central point of contact for and provide technical assistance to entities dealing with these issues, and develop legislative recommendations to strengthen critical supply chains for pandemics. The office shall cease to exist 18 months after the COVID-19 public health emergency (and any renewal thereof) is terminated.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2025 · first_quarter · Retirement
Public Law 117-328 Consolidated Appropriations Act of 2023. Issue: SECURE 2.0 implementation. HR 1024/S 424 Fairness for Charities and Educational Institutions Act of 2023. Issue: expansion of investment options for 403(b) plans. HR 10467 Retirement Simplification and Clarity Act. Issue: individual retirement annuities. No bill number. Department of Labor's proposed regulation defining fiduciary for investment advice purposes. No bill number. lifetime income products in qualified retirement plans.
Client expense: $470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $5,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · third_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · second_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2024 · first_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2023 · fourth_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · third_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · second_quarter · Animals
H.R. 1024, Humane Research and Testing Act of 2022
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · first_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and topics related to the FDA Modernization Act of 2021. Brief conversations with staff members addressed past and current legislative efforts to replace animal testing with non-animal methods, anticipated public benefits of modernizing medical research to be human-centered, the need to extend research protections to nonhuman animals.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medical/Disease Research/Clinical Labs
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and issues related to the FDA Modernization Act of 2021. Brief conversations with staff members discussed patient benefits of modernize medical testing.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Animals
HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · first_quarter · Manufacturing
White House Office of Supply Chain S.Con.Res.5, Budget Reconciliation (Office of Supply Chain) HR 1024, COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260, United States Innovation and Competition Act HR 2731, Endless Frontiers Act H.R.4996, Ocean Shipping Reform Act of 2021 H.R.4521 - America COMPETES Act of 2022
Client expense: $372,777 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2022 · first_quarter · Chemicals/Chemical Industry
H.R. 1024, COVID-19 Supply Chain Resiliency Act of 2021; H.R. 1062, ACCESS 45Q Act; H.R. 1512, CLEAN future Act; H.R. 1848, Leading Infrastructure for Tomorrow's America Act; H.R. 1855, Promoting New Manufacturing Act; H.R. 2159, RECYCLE Act; H.R. 2238, Break Free from Plastics Act 2021; H.R. 2357, RECOVER Act; H.R. 2467, PFAS Action Act of 2021; H.R. 2471, Consolidated Appropriations Act 2022; H.R. 2777, Advanced Recycling Research and Development Act of 2021; H.R. 2821, Plastic Waste Reduction and Recycling Research Act; H.R. 3538, Coordinated Action To Capture Harmful Emissions Act; H.R. 3633, Greener Transportation for Communities Act; H.R. 3684, Infrastructure Investment and Jobs Act; H.R. 4024, Zero-Emission Nuclear Power Production Credit Act of 2021; H.R. 4253, To require the Administrator of the Environmental Protection Agency to promulgate a national primary drinking water regulation for chromium-6, and for other purposes; H.R. 4309, Clean Energy Innovation and Deployment Act of 2021; H.R. 4334, American Energy First Act; H.R. 4350, National Defense Authorization Act for FY 2022; H.R. 4408, Carbon Capture Improvement Act of 2021; H.R. 4427, Brownfields Redevelopment Tax Incentive Reauthorization Act of 2021; H.R. 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act FY2022; H.R. 4534, FAIR Transition and Competition Act; H.R. 4559, Department of Defense Climate Resiliency and Readiness Act; H.R. 4720, Energy Sector Innovation Credit Act of 2021; H.R. 4996, Ocean Shipping Reform Act of 2021; H.R. 5279, Defense Energy Efficiency Act; H.R. 5376, Build Back Better Act; H.R. 5389, REDUCE Act of 2021; H.R. 5537, Toxic-free Beauty Act of 2021; H.R. 5538, Cosmetic Fragrance and Flavor Ingredient Right to know Act of 2021; H.R. 5539, Cosmetic Supply Chain Transparency Act of 2021; H.R. 5540, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2021; H.R. 6277, Ethylene is Essential for Chemistry and Manufacturing Act; H.R. 6562, CLEAR Act; H.R. 6787, Gas Prices Relief Act of 2022; S. 749, American Innovation and Jobs Act; S. 923, RECYCLE Act of 2021; S. 984, Break Free from Plastics Act 2021; S. 1260, US Innovation and Competition Act of 2021; S. 1605, National Defense Authorization Act for FY2022; S. 1791, FAST Electricity Act; S. 1807, Clean H2 Production Act; S. 1829, Carbon Capture Improvement Act of 2021; S. 2085, Save Our Future Act; S. 2100, Personal Care Products Safety Act; S. 2183, Superfund Polluter Pays Restoration Act of 2021; S. 2291, Zero-Emission Nuclear Power Production Credit Act of 2021; S. 2324, Federal Permitting Reform and Jobs Act; S. 2378, FAIR Transition and Competition Act; S. 2475, Energy Sector Innovation Credit Act of 2021; S. 2501, Offshore Wind Jobs and Opportunity Act; S. 2645, REDUCE Act of 2021; S. 2792, National Defense Authorization Act for FY2022; S. 3305, Chemical Tax Repeal Act; S. 3609, Gas Prices Relief Act of 2022; S. 3742, Recycling Infrastructure and Accessibility Act; S. 3743, Recycling and Composting Accountability Act; 86Fed.Reg. 50296, Advance Notice of Proposed Rulemaking for Pyrolysis and Gasification Units; S.Res.304, A resolution designation July 2021 as "Plastic Pollution Action Month"; S.J.Res.14, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Oil and Natural Gas Sector: Emission Standards for New, Reconstructed, and Modified Sources Review"; FY2022 Department of the Interior, Environment, and Related Agencies Appropriations; FY2022 Senate Inter-Environment Appropriations bill; Unintroduced 5 Actions for Sustainable Change Draft Legislation; Unintroduced legislation related to the Pesticide Registration Improvement Act; EO 14057, Executive Order Catalyzing Americas Clean Energy Economy Through Federal Sustainability; Alan Reinstein Ban Asbestos Now Act of 2021; Basel Convention Ratification; Carbon Border Adjustment Mechanism; Chemical Management; Climate policy/carbon emissions reduction; CPSC Commissioner Outreach; COVID Liability; FDA recycled content in food contact packaging; FIFRA Registration Review; Formaldehyde IRIS assessment; Innovative Materials for America's Growth and Infrastructure Newly Expanded (IMAGINE) Act; Nomination of Carlton Waterhouse to be EPA Assistant Administrator for the Office of Land and Emergency Management; Plastics Recycling Growth Act of 2021; PFAS Action Plan Issues; Regulation of Asbestos; Spray Foam Policy; Superfund Tax; The Recycling Partnership's Producer Responsibility Legislation; The use of advanced materials in infrastructure; TSCA Implementation (including low volume exemptions)
2022 · second_quarter · Manufacturing
White House Office of Supply Chain S.Con.Res.5, Budget Reconciliation (Office of Supply Chain) H.R. 1024 COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.260, United States Innovation and Competition Act H.R. 2731, Endless Frontiers Act H.R.4996, Ocean Shipping Reform Act of 2021 H.R.4521 - America COMPETES Act of 2022
Client expense: $372,777 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2021 · third_quarter · Manufacturing
White House Office of Supply Chain S.Con.Res.5, Budget Reconciliation (Office of Supply Chain) HR 1024, COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260, United States Innovation and Competition Act HR 2731, Endless Frontiers Act
Client expense: $268,959 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Manufacturing
White House Office of Supply Chain H.R. 1024 COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260 United States Innovation and Competition Act H.R. Endless Frontiers Act
Client expense: $518,508 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Chemicals/Chemical Industry
H.R. 1024, COVID-19 Supply Chain Resiliency Act of 2021; H.R. 1062, ACCESS 45Q Act; H.R. 1512, CLEAN future Act; H.R. 1848, Leading Infrastructure for Tomorrow's America Act; H.R. 1855, Promoting New Manufacturing Act; H.R. 2159, RECYCLE Act; H.R. 2238, Break Free from Plastics Act 2021; H.R. 2357, RECOVER Act; H.R. 2467, PFAS Action Act of 2021; H.R. 2777, Advanced Recycling Research and Development Act of 2021; H.R. 2821, Plastic Waste Reduction and Recycling Research Act; H.R. 3538, Coordinated Action To Capture Harmful Emissions Act; H.R. 3633, Greener Transportation for Communities Act; H.R. 3684, Infrastructure Investment and Jobs Act; H.R. 4024, Zero-Emission Nuclear Power Production Credit Act of 2021; H.R. 4253, To require the Administrator of the Environmental Protection Agency to promulgate a national primary drinking water regulation for chromium-6, and for other purposes; H.R. 4309, Clean Energy Innovation and Deployment Act of 2021; H.R. 4334, American Energy First Act; H.R. 4350, National Defense Authorization Act for FY 2022; H.R. 4408, Carbon Capture Improvement Act of 2021; H.R. 4427, Brownfields Redevelopment Tax Incentive Reauthorization Act of 2021; H.R. 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act FY2022; H.R. 4534, FAIR Transition and Competition Act; H.R. 4559, Department of Defense Climate Resiliency and Readiness Act; H.R. 4720, Energy Sector Innovation Credit Act of 2021; H.R. 4996, Ocean Shipping Reform Act of 2021; H.R. 5279, Defense Energy Efficiency Act; H.R. 5376, Build Back Better Act; H.R. 5389, REDUCE Act of 2021; H.R. 5537, Toxic-free Beauty Act of 2021; H.R. 5538, Cosmetic Fragrance and Flavor Ingredient Right to know Act of 2021; H.R. 5539, Cosmetic Supply Chain Transparency Act of 2021; H.R. 5540, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2021; H.R. 6277, Ethylene is Essential for Chemistry and Manufacturing Act; S. 749, American Innovation and Jobs Act; S. 923, RECYCLE Act of 2021; S. 984, Break Free from Plastics Act 2021; S. 1260, US Innovation and Competition Act of 2021; S. 1605, National Defense Authorization Act for FY2022; S. 1791, FAST Electricity Act; S. 1807, Clean H2 Production Act; S. 1829, Carbon Capture Improvement Act of 2021; S. 2085, Save Our Future Act; S. 2100, Personal Care Products Safety Act; S. 2183, Superfund Polluter Pays Restoration Act of 2021; S. 2291, Zero-Emission Nuclear Power Production Credit Act of 2021; S. 2324, Federal Permitting Reform and Jobs Act; S. 2378, FAIR Transition and Competition Act; S. 2475, Energy Sector Innovation Credit Act of 2021; S. 2501, Offshore Wind Jobs and Opportunity Act; S. 2645, REDUCE Act of 2021; S. 2792, National Defense Authorization Act for FY2022; S. 3305, Chemical Tax Repeal Act; 86Fed.Reg. 50296, Advance Notice of Proposed Rulemaking for Pyrolysis and Gasification Units; S.Res.304, A resolution designation July 2021 as "Plastic Pollution Action Month"; S.J.Res.14, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Oil and Natural Gas Sector: Emission Standards for New, Reconstructed, and Modified Sources Review"; FY2022 Department of the Interior, Environment, and Related Agencies Appropriations; FY2022 Senate Inter-Environment Appropriations bill; Unintroduced legislation related to the Pesticide Registration Improvement Act; EO 14057, Executive Order Catalyzing Americas Clean Energy Economy Through Federal Sustainability; Alan Reinstein Ban Asbestos Now Act of 2021; Basel Convention Ratification; Carbon Border Adjustment Mechanism; Chemical Management; Climate policy/carbon emissions reduction; CPSC Commissioner Outreach; COVID Liability; FDA recycled content in food contact packaging; FIFRA Registration Review; Formaldehyde IRIS assessment; Innovative Materials for America's Growth and Infrastructure Newly Expanded (IMAGINE) Act; Nomination of Carlton Waterhouse to be EPA Assistant Administrator for the Office of Land and Emergency Management; Nomination of Sylvia Johnson, Steve Owens and Jennifer Sass to the Chemical Safety Board (CSB); Plastics Recycling Growth Act of 2021; PFAS Action Plan Issues; Regulation of Asbestos; Spray Foam Policy; Superfund Tax; The Recycling Partnership's Producer Responsibility Legislation; The use of advanced materials in infrastructure; TSCA Implementation (including low volume exemptions)
2021 · fourth_quarter · Manufacturing
White House Office of Supply Chain S.Con.Res.5, Budget Reconciliation (Office of Supply Chain) HR 1024, COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260, United States Innovation and Competition Act HR 2731, Endless Frontiers Act
Client expense: $380,824 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), White House Office
2021 · second_quarter · Manufacturing
White House Office of Supply Chain H.R. 1024 COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260 United States Innovation and Competition Act H.R. Endless Frontiers Act
Client expense: $518,508 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Manufacturing
White House Office of Supply Chain S.Con.Res.5, Budget Reconciliation (Office of Supply Chain) HR 1024, COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260, United States Innovation and Competition Act HR 2731, Endless Frontiers Act
Client expense: $268,959 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), White House Office
2021 · second_quarter · Manufacturing
Issues related to Supply Chain efficiency H.R.1024 (COVID-19 Chain Resiliency Act of 2021)
Client expense: Not reported · Firm income: $50,000
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · second_quarter · Trade (domestic/foreign)
H.R. 1024: COVID-19 Supply Chain Resiliency Act of 2021 - Provisions related to medical supply chains H.R. 2731: Endless Frontier Act - Provisions related to medical supply chains and domestic manufacturing H.R. 3035: Preventing Foreign Attempts to Erode Healthcare Innovation Act - Provisions related to WTO TRIPS patent waivers and intellectual property H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes H.R. 3811: To direct the President to oppose any waiver of obligations of members of the World Trade Organization under the Agreement on Trade-Related Aspects of Intellectual Property Rights unless a statute is enacted expressly authorizing such a waiver - Provisions related to WTO TRIPS patent waivers and intellectual property S. 1203: MMEDS Act of 2021 - Provisions related to medical supply chains and domestic manufacturing S. 1260: United States Innovation and Competition Act of 2021 - Provisions related to medical supply chains and domestic manufacturing S. 1366: Pharmaceutical Supply Chain Defense and Enhancement Act - Provisions related to medical supply chains and domestic manufacturing S. 1367: United States Pharmaceutical Supply Chain Review Act - Provisions related to medical supply chains and domestic manufacturing S. 1388: Prescription Pricing for the People Act of 2021 - Provisions related to medical supply chains and prescription drug pricing transparency S. 1683: Preventing Foreign Attempts to Erode Healthcare Innovation Act - Provisions related to WTO TRIPS patent waivers and intellectual property S. 1693: To amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes - Provisions related to medical supply chains Protecting American Innovation Act - Provisions related to waiver Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver
2021 · second_quarter · Manufacturing
White House Office of Supply Chain H.R. 1024 COVID-19 Supply Chain Resiliency Act of 2021 E.O. 14017, Food System Supply Chains S.1260 United States Innovation and Competition Act H.R. Endless Frontiers Act
Client expense: $473,207 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Trade (domestic/foreign)
H.R. 1024: COVID-19 Supply Chain Resiliency Act of 2021 - Provisions related to medical supply chains H.R. 2731: Endless Frontier Act - Provisions related to medical supply chains and domestic manufacturing H.R. 3035: Preventing Foreign Attempts to Erode Healthcare Innovation Act - Provisions related to WTO TRIPS patent waivers and intellectual property H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes H.R. 3811: To direct the President to oppose any waiver of obligations of members of the World Trade Organization under the Agreement on Trade-Related Aspects of Intellectual Property Rights unless a statute is enacted expressly authorizing such a waiver - Provisions related to WTO TRIPS patent waivers and intellectual property S. 1203: MMEDS Act of 2021 - Provisions related to medical supply chains and domestic manufacturing S. 1260: United States Innovation and Competition Act of 2021 - Provisions related to medical supply chains and domestic manufacturing S. 1366: Pharmaceutical Supply Chain Defense and Enhancement Act - Provisions related to medical supply chains and domestic manufacturing S. 1367: United States Pharmaceutical Supply Chain Review Act - Provisions related to medical supply chains and domestic manufacturing S. 1388: Prescription Pricing for the People Act of 2021 - Provisions related to medical supply chains and prescription drug pricing transparency S. 1683: Preventing Foreign Attempts to Erode Healthcare Innovation Act - Provisions related to WTO TRIPS patent waivers and intellectual property S. 1693: To amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes - Provisions related to medical supply chains Protecting American Innovation Act - Provisions related to waiver Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver
2021 · first_quarter · Trade (domestic/foreign)
H.R. 171: Resilient Manufacturing Task Force Act of 2021 - Provisions related to medical supply chains and domesic manufacturing H.R. 1024: COVID-19 Supply Chain Resiliency Act of 2021 - Provisions related to medical supply chains H.R. 1186: Supply Chain Security and Pharmaceutical Authentication Act of 2021 - Provisions related to medical supply chains H.R. 2279: To establish the Office of Manufacturing and Industrial Innovation Policy and strategic national manufacturing policy for the United States, to provide manufacturing and industrial perspective and advice to the President, to provide for a comprehensive survey and cross administration management of efforts to ensure global leadership in manufacturing critical to the long-term economic health and national security of the United States, and for other purposes. - Provisions related to medical supply chains S. 298: Pharmacy Benefit Manager Accountability Study Act of 20201 - To require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues
Client expense: $1,800,000 · Firm income: Not reported
2021 · first_quarter · Trade (domestic/foreign)
H.R. 171: Resilient Manufacturing Task Force Act of 2021 - Provisions related to medical supply chains and domesic manufacturing H.R. 1024: COVID-19 Supply Chain Resiliency Act of 2021 - Provisions related to medical supply chains H.R. 1186: Supply Chain Security and Pharmaceutical Authentication Act of 2021 - Provisions related to medical supply chains H.R. 2279: To establish the Office of Manufacturing and Industrial Innovation Policy and strategic national manufacturing policy for the United States, to provide manufacturing and industrial perspective and advice to the President, to provide for a comprehensive survey and cross administration management of efforts to ensure global leadership in manufacturing critical to the long-term economic health and national security of the United States, and for other purposes - Provisions related to medical supply chains S. 298: Pharmacy Benefit Manager Accountability Study Act of 20201 - To require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues
Client expense: $8,540,000 · Firm income: Not reported
| Republican |
| SD |
Client expense: $3,130,000 · Firm income: Not reported
Government targets: Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
Client expense: $7,320,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Railroad Administration, HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Client expense: $1,300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Client expense: $6,430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)